These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2014466)

  • 1. Primary biliary cirrhosis and scleroderma complicated by Barrett's oesophagus. A case report.
    Chang CP; Huang YS; Tsay SH; Lai KH; Lee SD
    S Afr Med J; 1991 Apr; 79(7):397-8. PubMed ID: 2014466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Barrett esophagus in systemic sclerosis].
    Szigeti N; Fábián G; Gömöri E; Czirják L
    Orv Hetil; 2001 Apr; 142(13):671-4. PubMed ID: 11338570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's oesophagus: a clinical study of 52 patients.
    Cooper BT; Barbezat GO
    Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplastic Barrett's esophagus in scleroderma.
    Sprung DJ; Gibb SP
    Am J Gastroenterol; 1985 Jul; 80(7):518-22. PubMed ID: 4014100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
    Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
    Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus complicating scleroderma.
    Agha FP; Dabich L
    Gastrointest Radiol; 1985; 10(4):325-9. PubMed ID: 4054496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
    Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
    Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
    Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
    Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus.
    Todd JA; Basu KK; de Caestecker JS
    Aliment Pharmacol Ther; 2005 Apr; 21(8):969-75. PubMed ID: 15813832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
    Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
    Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
    Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus with adenocarcinoma in scleroderma.
    McKinley M; Sherlock P
    Am J Gastroenterol; 1984 Jun; 79(6):438-9. PubMed ID: 6731415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.